Anterior Cruciate Ligament RuptureNCT04390035
BFRT in Adolescents After ACL Reconstruction
A study testing Blood Flow Restriction using Delfi Personalized Tourniquet System in people with Anterior Cruciate Ligament Rupture, run by Children's Healthcare of Atlanta at 1 site in United States.
Trial summary
This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). Read more about this study
- Who is it for?
- Ages 12 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Anterior Cruciate Ligament Rupture
- What is being tested?
- Blood Flow Restriction using Delfi Personalized Tourniquet System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteUnited States
- Study dates
- 23 Sep 2020to Apr 2023
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Adolescent male and female patients, age 12-18
- Skeletally mature at time of diagnosis, with closed growth plates, as determined via standard clinic x-ray imaging (this specification automatically excludes pre-pubescent children.
- Underwent transphyseal ACLR with quadriceps tendon autograft with one of three sports orthopedic surgeons at CHOA
- Completed pre-surgery strength assessment of bilateral quadriceps, hamstrings, hip abductor and hip adductor musculature.
- English-speaking adolescents and parents of all races and ethnicities (after preliminary data is achieved, PI will coordinate a larger multi-center study that will include all non-English speaking participants.
Who cannot join
- Skeletally immature patients with open growth plates, as determined via standard clinic x-ray imaging
- Concomitant procedures performed during ACLR which require weight-bearing restrictions (i.e. meniscus repair, microfracture, multi-ligament knee reconstruction)
- History of previous knee surgery
- History of cardiovascular disease (e.g. coronary artery disease, unstable hypertension, vascular endothelial dysfunction, peripheral artery disease, varicose veins)
- ICD-10 diagnosis of bleeding disorder (e.g. hemophilia or blood clotting disorder) or use of anticoagulants or other medications that may affect blood clotting
- Inability to adhere to treatment protocol (as described in study procedures, BFR-LLT treatment requirements)
Show all 10Show fewer
- Any adverse events intra-operatively or post-operatively that lead to delay in care, including infection
- Failure to adhere to attendance requirements as detailed below:
- Attend first PT visit (PTV) within 5 days post-surgery
- Attend a minimum of 20 total PTVs during weeks 1-16 post-surgery
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Children's Healthcare of Atlanta Physical Therapy
Atlanta, Georgia, 30342-3269
Jeanne Graf, PT, DPT, ATC, 404-785-8421, jeannie.graf@choa.org
About this study
Official title: Blood Flow Restriction Training in the Adolescent Patient: Effects on Muscle Strength and Overall Function Following Anterior Cruciate Ligament Reconstruction Surgery
This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). The study aims to identify the effect of BFRT on quadriceps muscle strength and the patient's quality of life, and the overall tolerability of BFRT will be examined. Eight physical therapists at four sports medicine physical therapy (PT) sites will oversee all post-operative PT sessions. Subjects allocated to the BFR group will undergo BFRT, while control group will undergo standard-of-care ACLR rehabilitation, 2 days per week for 16 weeks. Measurements of strength, quality of life, and overall function will be completed at regular intervals.
Read the detailed description
Background:
Approximately 100,000 anterior cruciate ligament reconstructions (ACLR) are performed yearly, and rates of these surgeries in patients younger than 15 years increased by 924% between 1990 and 2007.1 Persistent strength deficits in quadriceps musculature following ACLR are common, even several months after surgery and despite targeted physical therapy to address atrophy.2 Quadriceps atrophy and weakness are associated with worse patient-reported outcomes (PROs),3 as well as altered movement strategies and increased risk of reinjury.4,6 Approximately 20% of teenagers returning to sports will sustain a second ACL injury in the first two years following their ACLR.5 Regaining neuromuscular activation and strength of the quadriceps muscle safely and efficiently is vital to full recovery, and current post-operative physical therapy regimens have not sufficiently addressed this impairment.
Strength training models recommend utilizing high resistance workloads to produce substantial strength gains,7 yet those recovering from orthopedic surgery are unable to tolerate heavy loads.8 Supplementing low-load resistance training with blood flow restriction (BFR-LLT) produces significant muscle hypertrophy and strength gains previously only thought to be achievable with high-load resistance training.9 BFR-LLT uses a tourniquet around the leg (see Appendix 4) to partially occlude venous return and decrease blood supply to the muscle being exercised. The generation of a low-oxygen environment and increases in plasma growth hormone levels has been shown to promote recruitment of motor units, improve neuromuscular activation, and result in muscular hypertrophy and growth.10-13 In adults and the elderly, improvements in quadriceps strength have been reported in up to 19%14 and increased quadriceps cross-sectional area in up to 6-7% compared to controls.15-16 To date there have only been four high-level studies investigating effects of BFR training in patients following ACLR17-20 and limited conclusions can be drawn from these studies due to lack of consistent methodology (variable cuff pressures and treatment frequency). More high-quality research is needed to determine treatment parameters that produce the most optimal results from this intervention in ACLR patients.
Additionally, there are no published randomized controlled trials investigating the effects of BFR training on exclusively adolescent patients. All high-quality BFR training research in patients following knee surgery have been conducted in late adolescent, young adult and adult populations.17-21 Therefore, the purpose of this study is to assess the effect of BFR-LLT on quadriceps strength and outcomes in adolescents following ACLR.
This study's adolescent-specific focus provides a significant contribution to ACLR research, as younger patients demonstrate higher risk of reinjury.22-24 The results from this preliminary study will ultimately provide data to guide clinicians in optimizing quadriceps strength and utilizing BFR-LLT in younger post-operative ACLR patients.
Protocol:
This randomized clinical trial is an interdisciplinary project between the CHOA Sports Medicine Physical Therapy department and Children's Physician Group (CPG) Orthopedics. As part of standard-of-care, all patients who plan to undergo ACLR by CPG Orthopedics surgeons are referred for at least one PT visit pre-surgery, at which time baseline strength measurements are obtained by the treating physical therapist. Pre-surgery collection of patient-reported outcomes (PROs) is also standard of care for all patients undergoing ACLR.
Skeletally mature male and female adolescents with closed growth plates documented by radiograph who undergo ACLR with quadriceps tendon autograft will be screened by a physical therapist (the PI or co-investigators) using medical notes.
If a patient meets criteria and consents, he/she will be enrolled into the study during the first routine-of-care post-surgery PT visit and randomized to undergo standard post-surgery rehabilitation (control group) or standard post-surgery rehabilitation with supplemental BFR-LLT (test group) as demonstrated in Figure 1 and Appendix 1. Participants will be randomized using a computer program that will generate random numbers to assign participants to the test group or the control group. Participants will be asked to complete four PROs throughout the study (Lysholm, Pedi-IKDC, ACL-RSI, and AMCaMP - see Appendix 5.1-5.4). All relevant demographic, physiological, and radiographic data will be collected at the time of enrollment via RedCap, through a secure link. Data will be stored in a password-protected file on a secure Children's server and only the PI, Co-investigators, and research coordinator will have access.
Eight physical therapists (all CITI-trained) at four sports medicine PT sites will oversee all post-surgery PT sessions. Participants in the control group will follow a standard post-surgery rehabilitation protocol starting 2-5 days post-surgery and attend two PT visits per week until 16 weeks post-surgery. The test group will follow an identical schedule of PT visits but will have two to three exercises in each session supplemented with BFR treatment using the Delfi Personalized Tourniquet System (PTS). Requirements of BFR treatment are described below. For both groups, each session will last approximately 60 minutes. Each of the exercises performed with BFR will last 5-18 minutes, with total time under occlusion not exceeding 30 minutes per visit.
Participants undergoing BFR treatment will wear limb protection sleeves designed to help protect the skin beneath the cuff while the cuff is pressurized. Skin integrity will be monitored pre- and post-treatment at each session. If a study participant reports intolerable pain levels during BFR, the physical therapist will fully deflate the cuff and BFR treatment will cease for that PT session. Any adverse events will be reported to the PI and Co-I's within 24 hours. All required medical assessments will be promptly performed.
If a participant is assigned to the test group, BFR intervention will end after 16 weeks post-surgery. Both the test group (BFR-LLT) and the control group will follow standard of care treatment after week 16 post-surgery, including the standard post-intervention functional testing at 24 weeks post-surgery.
Participants will be asked to complete PROs periodically throughout the study as listed below under data collection. All physical examination measures and testing listed are standard of care for ACLR rehabilitation patients. Details on the regimen followed by both cohorts during the full 6-month rehabilitation are outlined in Appendix 1.
BFR-LLT Treatment Requirements:
The BFR-LLT intervention requires participants to follow the two requirements listed below, as the treatment parameter of 80% LOP has been widely recommended as the ideal amount of blood flow occlusion throughout the literature. Participants who do not meet these criteria will be excluded from the study but will continue to receive standard of care for post-surgery ACLR rehabilitation.
- Tolerate a personalized pressure of 80% of the limb occlusion pressure (LOP) for 100% of all physical therapy visits in which BFR-LLT is utilized.
- Tolerate BFR-LLT for a minimum of 20 visits over 16 weeks.
Data Collection:
- Demographic data (pre-surgery, which is standard of care) will include age, gender, race/ethnicity, height/weight, physeal status, and assessment of baseline activity level with the Tegner Activity Scale (see Appendix 6)
- Patient-reported outcomes (PROs) (see Appendix 5) will include the Pediatric Internal Knee Documentation Committee (Pedi-IKDC, Appendix 5.1), Lysholm Score (Appendix 5.2), ACL-Return to Sport after Injury (ACL-RSI) confidence assessment (Appendix 5.3) and Adolescent Measure of Confidence and Musculoskeletal Performance (AMCaMP,Appendix 5.4). These PROs are collected pre-surgery as standard of care, but further collection and reassessment of PROs as described in Figure 2 will be unique to study participants. Surveys will be collected and recorded on iPads with direct entry into REDCap and in each participant's confidential EHR on the treatment note from the day the data was collected. All responses will be stored on a secure RedCap server through a secure link and data will be stored in a password-protected file on a secure Children's server. Only the PI and Co-I's will have access to the data.
- Conditions
- Anterior Cruciate Ligament Rupture
- Being tested
- Blood Flow Restriction using Delfi Personalized Tourniquet System
- Keywords
- Adolescents, Blood Flow Restriction Training, Patient-reported Outcomes
- Medical subject headings
- Anterior Cruciate Ligament Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Blood Flow Restriction using Delfi Personalized Tourniquet SystemDevice
Participants assigned to the test group will undergo blood flow restriction training 2 days per week beginning at week 1-2 post-surgery and continuing through week 16 post-surgery using the FDA-approved Delfi Personalized Tourniquet System (PTS) with personalized pressure of 80% of the limb occlusion pressure (LOP). The LOP is the amount of pressure required to fully occlude arterial and venous blood flow to the limb. Otherwise, both the test group and control group will follow a standard 6-month post-surgery rehabilitation protocol which is standard of care for ACLR recovery.
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Participants in the control arm will follow the standard-of-care treatment exercises for the 6 months following ACL reconstruction surgery. |
| Test (BFRT) | Experimental | Participants in the test arm will follow the identical physical therapy exercises as the control arm but will perform the exercises with BFRT during the first 16 weeks post-surgery. After reaching the 16-week mark, participants will complete the identical standard-of-care rehabilitation between weeks 16-24. Receives: Device: Blood Flow Restriction using Delfi Personalized Tourniquet System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quadriceps Strength
Quadriceps strength will be evaluated throughout the study using handheld dynamometry and percentage improvement will be compared between the control group and intervention group.
Measured: 0-24 weeks post-surgery
Hop Test Results
The hop test battery includes four hop tests (single leg hop for distance, triple hop for distance, 6-meter timed hop, triple crossover hop). Symmetry of performance between operative and non-operative lower extremity will be compared between control group and intervention group. The test will be performed at 24 weeks post-surgery.
Measured: 24 weeks
Y-Balance Test Results
Symmetry of performance between operative and non-operative lower extremity will be compared between control group and intervention group. This test will be performed at 24 weeks post-surgery.
Measured: 24 weeks
Secondary outcomes (3)
Quality of life via Lysholm Knee Scale Score
The Lysholm Knee Scoring Scale is a patient-reported outcome which will be used to assess participant quality of life throughout the recovery following surgery. This tool asks eight questions and the score total ranges from 0-100 with 100 being the better outcome.
Measured: At time of enrollment and 6, 12, and 24 weeks post-surgery
Discomfort during BFRT via Visual Analogue Scale
The Visual Analogue scale is a patient-reported outcome, the score ranges from 0 - 10, with 0 being no pain. Pain level pre-treatment and during training will be assessed at each session
Measured: 0-16 weeks post-surgery
Perceived Exertion during BFRT via the Children's OMNI Resistance Training Scale.
The children's OMNI resistance training scale is a patient-reported outcome, the score ranges from 0 - 10, with 0 being no exertion. Perceived exertion will be assessed at each treatment session.
Measured: 0-16 weeks post-surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2020
- Study start23 Sep 2020
- Primary completionApr 2023 (estimated)
- Study completionApr 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anterior Cruciate Ligament RuptureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomized into either a control group or the test group at time of enrollment at a 1:1 ratio. Participants will undergo standard post-surgery rehabilitation (control group) or standard post-surgery rehabilitation with supplemental blood flow restriction (test group).
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Children's Healthcare of Atlanta
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jeanne Perkis, Children's Healthcare of Atlanta
- Investigators
- Jeanne Graf, PT, DPT, ATC, Principal investigator, Clinical Site Supervisor, Physical Therapist
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04390035
- Sponsor's protocol ID
- STUDY00000434
- Status last verified
- Jul 2021
- First submitted
- 12 May 2020
- Last updated
- 2 Aug 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No: There is no plan to make IPD available.
Study at a glance
From the registry record, last updated by the sponsor on 2 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Blood Flow Restriction Training in the Adolescent Patient: Effects on Muscle Strength and Overall Function Following Anterior Cruciate Ligament Reconstruction Surgery
- ClinicalTrials.gov ID
- NCT04390035
- Acronym / sponsor ID
- STUDY00000434
- Conditions
- Anterior Cruciate Ligament Rupture
- Keywords
- Adolescents, Blood Flow Restriction Training, Patient-reported Outcomes
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Children's Healthcare of AtlantaUniversity, hospital or other
- Study start
- 23 Sep 2020 (actual)
- Primary completion
- Apr 2023 (estimated)
- Study completion
- Apr 2023 (estimated)
- First posted
- 15 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). The study aims to identify the effect of BFRT on quadriceps muscle strength and the patient's quality of life, and the overall tolerability of BFRT will be examined. Eight physical therapists at four sports medicine physical therapy (PT) sites will oversee all post-operative PT sessions. Subjects allocated to the BFR group will undergo BFRT, while control group will undergo standard-of-care ACLR rehabilitation, 2 days per week for 16 weeks. Measurements of strength, quality of life, and overall function will be completed at regular intervals.
Detailed description
Background:
Approximately 100,000 anterior cruciate ligament reconstructions (ACLR) are performed yearly, and rates of these surgeries in patients younger than 15 years increased by 924% between 1990 and 2007.1 Persistent strength deficits in quadriceps musculature following ACLR are common, even several months after surgery and despite targeted physical therapy to address atrophy.2 Quadriceps atrophy and weakness are associated with worse patient-reported outcomes (PROs),3 as well as altered movement strategies and increased risk of reinjury.4,6 Approximately 20% of teenagers returning to sports will sustain a second ACL injury in the first two years following their ACLR.5 Regaining neuromuscular activation and strength of the quadriceps muscle safely and efficiently is vital to full recovery, and current post-operative physical therapy regimens have not sufficiently addressed this impairment.
Strength training models recommend utilizing high resistance workloads to produce substantial strength gains,7 yet those recovering from orthopedic surgery are unable to tolerate heavy loads.8 Supplementing low-load resistance training with blood flow restriction (BFR-LLT) produces significant muscle hypertrophy and strength gains previously only thought to be achievable with high-load resistance training.9 BFR-LLT uses a tourniquet around the leg (see Appendix 4) to partially occlude venous return and decrease blood supply to the muscle being exercised. The generation of a low-oxygen environment and increases in plasma growth hormone levels has been shown to promote recruitment of motor units, improve neuromuscular activation, and result in muscular hypertrophy and growth.10-13 In adults and the elderly, improvements in quadriceps strength have been reported in up to 19%14 and increased quadriceps cross-sectional area in up to 6-7% compared to controls.15-16 To date there have only been four high-level studies investigating effects of BFR training in patients following ACLR17-20 and limited conclusions can be drawn from these studies due to lack of consistent methodology (variable cuff pressures and treatment frequency). More high-quality research is needed to determine treatment parameters that produce the most optimal results from this intervention in ACLR patients.
Additionally, there are no published randomized controlled trials investigating the effects of BFR training on exclusively adolescent patients. All high-quality BFR training research in patients following knee surgery have been conducted in late adolescent, young adult and adult populations.17-21 Therefore, the purpose of this study is to assess the effect of BFR-LLT on quadriceps strength and outcomes in adolescents following ACLR.
This study's adolescent-specific focus provides a significant contribution to ACLR research, as younger patients demonstrate higher risk of reinjury.22-24 The results from this preliminary study will ultimately provide data to guide clinicians in optimizing quadriceps strength and utilizing BFR-LLT in younger post-operative ACLR patients.
Protocol:
This randomized clinical trial is an interdisciplinary project between the CHOA Sports Medicine Physical Therapy department and Children's Physician Group (CPG) Orthopedics. As part of standard-of-care, all patients who plan to undergo ACLR by CPG Orthopedics surgeons are referred for at least one PT visit pre-surgery, at which time baseline strength measurements are obtained by the treating physical therapist. Pre-surgery collection of patient-reported outcomes (PROs) is also standard of care for all patients undergoing ACLR.
Skeletally mature male and female adolescents with closed growth plates documented by radiograph who undergo ACLR with quadriceps tendon autograft will be screened by a physical therapist (the PI or co-investigators) using medical notes.
If a patient meets criteria and consents, he/she will be enrolled into the study during the first routine-of-care post-surgery PT visit and randomized to undergo standard post-surgery rehabilitation (control group) or standard post-surgery rehabilitation with supplemental BFR-LLT (test group) as demonstrated in Figure 1 and Appendix 1. Participants will be randomized using a computer program that will generate random numbers to assign participants to the test group or the control group. Participants will be asked to complete four PROs throughout the study (Lysholm, Pedi-IKDC, ACL-RSI, and AMCaMP - see Appendix 5.1-5.4). All relevant demographic, physiological, and radiographic data will be collected at the time of enrollment via RedCap, through a secure link. Data will be stored in a password-protected file on a secure Children's server and only the PI, Co-investigators, and research coordinator will have access.
Eight physical therapists (all CITI-trained) at four sports medicine PT sites will oversee all post-surgery PT sessions. Participants in the control group will follow a standard post-surgery rehabilitation protocol starting 2-5 days post-surgery and attend two PT visits per week until 16 weeks post-surgery. The test group will follow an identical schedule of PT visits but will have two to three exercises in each session supplemented with BFR treatment using the Delfi Personalized Tourniquet System (PTS). Requirements of BFR treatment are described below. For both groups, each session will last approximately 60 minutes. Each of the exercises performed with BFR will last 5-18 minutes, with total time under occlusion not exceeding 30 minutes per visit.
Participants undergoing BFR treatment will wear limb protection sleeves designed to help protect the skin beneath the cuff while the cuff is pressurized. Skin integrity will be monitored pre- and post-treatment at each session. If a study participant reports intolerable pain levels during BFR, the physical therapist will fully deflate the cuff and BFR treatment will cease for that PT session. Any adverse events will be reported to the PI and Co-I's within 24 hours. All required medical assessments will be promptly performed.
If a participant is assigned to the test group, BFR intervention will end after 16 weeks post-surgery. Both the test group (BFR-LLT) and the control group will follow standard of care treatment after week 16 post-surgery, including the standard post-intervention functional testing at 24 weeks post-surgery.
Participants will be asked to complete PROs periodically throughout the study as listed below under data collection. All physical examination measures and testing listed are standard of care for ACLR rehabilitation patients. Details on the regimen followed by both cohorts during the full 6-month rehabilitation are outlined in Appendix 1.
BFR-LLT Treatment Requirements:
The BFR-LLT intervention requires participants to follow the two requirements listed below, as the treatment parameter of 80% LOP has been widely recommended as the ideal amount of blood flow occlusion throughout the literature. Participants who do not meet these criteria will be excluded from the study but will continue to receive standard of care for post-surgery ACLR rehabilitation.
- Tolerate a personalized pressure of 80% of the limb occlusion pressure (LOP) for 100% of all physical therapy visits in which BFR-LLT is utilized.
- Tolerate BFR-LLT for a minimum of 20 visits over 16 weeks.
Data Collection:
- Demographic data (pre-surgery, which is standard of care) will include age, gender, race/ethnicity, height/weight, physeal status, and assessment of baseline activity level with the Tegner Activity Scale (see Appendix 6)
- Patient-reported outcomes (PROs) (see Appendix 5) will include the Pediatric Internal Knee Documentation Committee (Pedi-IKDC, Appendix 5.1), Lysholm Score (Appendix 5.2), ACL-Return to Sport after Injury (ACL-RSI) confidence assessment (Appendix 5.3) and Adolescent Measure of Confidence and Musculoskeletal Performance (AMCaMP,Appendix 5.4). These PROs are collected pre-surgery as standard of care, but further collection and reassessment of PROs as described in Figure 2 will be unique to study participants. Surveys will be collected and recorded on iPads with direct entry into REDCap and in each participant's confidential EHR on the treatment note from the day the data was collected. All responses will be stored on a secure RedCap server through a secure link and data will be stored in a password-protected file on a secure Children's server. Only the PI and Co-I's will have access to the data.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be randomized into either a control group or the test group at time of enrollment at a 1:1 ratio. Participants will undergo standard post-surgery rehabilitation (control group) or standard post-surgery rehabilitation with supplemental blood flow restriction (test group).
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –Participants in the control arm will follow the standard-of-care treatment exercises for the 6 months following ACL reconstruction surgery. |
| Test (BFRT) | Experimental | Device: Blood Flow Restriction using Delfi Personalized Tourniquet SystemParticipants in the test arm will follow the identical physical therapy exercises as the control arm but will perform the exercises with BFRT during the first 16 weeks post-surgery. After reaching the 16-week mark, participants will complete the identical standard-of-care rehabilitation between weeks 16-24. |
Who may qualify
- Ages
- 12 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (5 listed)
- Adolescent male and female patients, age 12-18
- Skeletally mature at time of diagnosis, with closed growth plates, as determined via standard clinic x-ray imaging (this specification automatically excludes pre-pubescent children.
- Underwent transphyseal ACLR with quadriceps tendon autograft with one of three sports orthopedic surgeons at CHOA
- Completed pre-surgery strength assessment of bilateral quadriceps, hamstrings, hip abductor and hip adductor musculature.
- English-speaking adolescents and parents of all races and ethnicities (after preliminary data is achieved, PI will coordinate a larger multi-center study that will include all non-English speaking participants.
Key exclusion criteria (10 listed)
- Skeletally immature patients with open growth plates, as determined via standard clinic x-ray imaging
- Concomitant procedures performed during ACLR which require weight-bearing restrictions (i.e. meniscus repair, microfracture, multi-ligament knee reconstruction)
- History of previous knee surgery
- History of cardiovascular disease (e.g. coronary artery disease, unstable hypertension, vascular endothelial dysfunction, peripheral artery disease, varicose veins)
- ICD-10 diagnosis of bleeding disorder (e.g. hemophilia or blood clotting disorder) or use of anticoagulants or other medications that may affect blood clotting
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Blood Flow Restriction using Delfi Personalized Tourniquet SystemParticipants assigned to the test group will undergo blood flow restriction training 2 days per week beginning at week 1-2 post-surgery and continuing through week 16 post-surgery using the FDA-approved Delfi Personalized Tourniquet System (PTS) with personalized pressure of 80% of the limb occlusion pressure (LOP). The LOP is the amount of pressure required to fully occlude arterial and venous blood flow to the limb. Otherwise, both the test group and control group will follow a standard 6-month post-surgery rehabilitation protocol which is standard of care for ACLR recovery. | Device | Test (BFRT) |
Primary outcome
Quadriceps Strength
Time frame: 0-24 weeks post-surgery
Quadriceps strength will be evaluated throughout the study using handheld dynamometry and percentage improvement will be compared between the control group and intervention group.
Hop Test Results
Time frame: 24 weeks
The hop test battery includes four hop tests (single leg hop for distance, triple hop for distance, 6-meter timed hop, triple crossover hop). Symmetry of performance between operative and non-operative lower extremity will be compared between control group and intervention group. The test will be performed at 24 weeks post-surgery.
Y-Balance Test Results
Time frame: 24 weeks
Symmetry of performance between operative and non-operative lower extremity will be compared between control group and intervention group. This test will be performed at 24 weeks post-surgery.
3 secondary outcomes
Quality of life via Lysholm Knee Scale Score
Time frame: At time of enrollment and 6, 12, and 24 weeks post-surgery
Discomfort during BFRT via Visual Analogue Scale
Time frame: 0-16 weeks post-surgery
Perceived Exertion during BFRT via the Children's OMNI Resistance Training Scale.
Time frame: 0-16 weeks post-surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Aug 2021.
- Individual participant dataSharing planned: No. There is no plan to make IPD available.
Related trials for Anterior Cruciate Ligament Rupture
Not yet recruiting
Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program
Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries
Not yet recruiting
Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Not yet recruitingPhase 3
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
RecruitingObservational study
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
ACL Tears
Recruiting
Quadriceps Strengthening ACL Reconstruction
ACL Tear
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jeanne Graf, PT, DPT, ATC principal investigator
Clinical Site Supervisor, Physical Therapist
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Blood Flow Restriction using Delfi Personalized Tourniquet System in people with Anterior Cruciate Ligament Rupture, run by Children's Healthcare of Atlanta at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jeanne Graf, PT, DPT, ATC (404-785-8421, jeannie.graf@chao.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quadriceps Strength (time frame: 0-24 weeks post-surgery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2021.